Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pelletier and Caventou was a landmark pharmaceutical partnership established by French chemists Pierre-Joseph Pelletier and Joseph Bienaimé Caventou in the early 19th century. The duo is renowned for the 1820 isolation of quinine from cinchona bark, a discovery that provided the first pure and effective treatment for malaria. Beyond quinine, they isolated several other critical alkaloids including strychnine, brucine, cinchonine, and emetine, laying the foundational principles for modern pharmacology. They established one of the first industrial-scale manufacturing facilities to produce these purified compounds, transitioning the field from traditional herbalism to chemical-based medicine. Their work is considered a cornerstone in the history of the life sciences and the development of the global pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on P.S. Pelletier and J.B. Caventou.